HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy

Genes and Immunity

Volumn 15, Issue 1, 2014, Pages 47-53

  Wu, T W ^a   Chu, C C ^b,c   Chang Liao, H W ^d   Lin, S K ^d   Ho, T Y ^d   Lin, M ^b   Lin, H H ^d,e   Wang, L Y ^a,d  

^a MACKAY MEDICAL COLLEGE   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Adolescents; Hepatitis B vaccination; HLA DPB1; Kinetics; Short term response

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HLA DPB1 ANTIGEN;

ADOLESCENT; ALLELE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD SAMPLING; CHILD; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HOMOZYGOTE; HUMAN; INFANT; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ALLELES; COHORT STUDIES; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HETEROZYGOTE; HLA-DP BETA-CHAINS; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFANT; KINETICS; LINEAR MODELS; MALE;

EID: 84895863710     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.62     Document Type: Article

References (55)

1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264-1273 e1
2. Liang TJ. Hepatitis B: The virus and disease. Hepatology 2009; 49: S13-S21
3. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. JHepatol 2008; 48: 335-352
4. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129
5. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O et al. Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up. Ann Intern Med 2005; 142: 333-341
6. Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987; 257: 2597-2603
7. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 1996; 276: 906-908
8. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30: 1312-1317
9. Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD et al. Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006; 24: 759-765
10. Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 2010; 51: 1547-1554
11. Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40: 1415-1420
12. Wu TW, Lin HH, Wang LY. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology 2013; 57: 37-45
13. Varla-Leftherioti M, Papanicolaou M, Spyropoulou M, Vallindra H, Tsiroyianni P, Tassopoulos N et al. HLA-Associated non-responsiveness to hepatitis B vaccine. Tissue Antigens 1990; 35: 60-63
14. Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: Multiple HLA genes are involved. Tissue Antigens 1998; 51: 593-604
15. Hatae K, Kimura A, Okubo R, Watanabe H, Erlich HA, Ueda K et al. Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype. Eur J Immunol 1992; 22: 1899-1905
16. Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A et al. Humoral response to recombinant hepatitis B virus vaccine at birth: Role of HLA and beyond. Clin Immunol 2000; 97: 234-240
17. McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997; 50: 8-14
18. Hsu HY, Chang MH, Ho HN, Hsieh RP, Lee SD, Chen DS et al. Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine 1993; 11: 1437-1440
19. Lin HH, Liao HW, Lin SK, Wang LY. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. Vaccine 2008; 26: 3414-3420
20. Wu TW, Chu CC, Ho TY, Chang Liao HW, Lin SK, Lin M et al. Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents. Hum Genet 2013; 132: 1131-1139
21. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41: 591-595
22. Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011; 53: 422-428
23. Li J, Yang D, He Y, Wang M, Wen Z, Liu L et al. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: A multicenter case-control study. PLoS One 2011; 6: E24221
24. Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, Li YP et al. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: Two independent case-control studies. PLoS One 2011; 6: E17608
25. Doherty PC, Zinkernagel RM. A biological role for the major histocompatibility antigens. Lancet 1975; 1: 1406-1409
26. Thursz MR, Thomas HC, Greenwood BM, Hill AV. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat genet 1997; 17: 11-12
27. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ et al. HLA and HIV-1: Heterozygote advantage and B. *35-Cw. *04 disadvantage. Science 1999; 283: 1748-1752
28. Hraber P, Kuiken C, Yusim K. Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection. Hepatology 2007; 46: 1713-1721
29. Bertoletti A, Tan AT, Gehring AJ. HBV-Specific Adaptive Immunity. Viruses 2009; 1: 91-103
30. Chisari FV. Cytotoxic T cells and viral hepatitis. J ClinInvest 1997; 99: 1472-1477
31. Guidotti LG, Chisari FV. To kill or to cure: Options in host defense against viral infection. Curr Opin Immunol 1996; 8: 478-483
32. Alberti A, Diana S, Sculard GH, Eddleston AL, Williams R. Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J 1978; 2: 1056-1058
33. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-229
34. Amanna IJ, Slifka MK. Contributions of humoral and cellular immunity to vaccineinduced protection in humans. Virology 2011; 411: 206-215
35. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999; 283: 1277-1278
36. Giron-Gonzalez JA, Moral FJ, Elvira J, Garcia-Gil D, Guerrero F, Gavilan I et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000; 143: 31-36
37. McMurray RW, Ndebele K, Hardy KJ, Jenkins JK. 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 2001; 14: 324-333
38. Vermeiren AP, Hoebe CJ, Dukers-Muijrers NH. High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. J Clin Virol 2013; 58: 262-264
39. Medina KL, Strasser A, Kincade PW. Estrogen influences the differentiation, proliferation and survival of early B-lineage precursors. Blood 2000; 95: 2059-2067
40. Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 2003; 33: 512-521
41. Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002; 109: 1625-1633
42. Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999; 103: 282-288
43. Palaszynski KM, Smith DL, Kamrava S, Burgoyne PS, Arnold AP, Voskuhl RR. A yin-yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 2005; 146: 3280-3285
44. Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008; 205: 1099-1108
45. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007; 357: 1903-1915
46. Leyendeckers H, Odendahl M, Lohndorf A, Irsch J, Spangfort M, Miltenyi S et al. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur J Immunol 1999; 29: 1406-1417
47. Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 2003; 48: 2146-2154
48. Chu VT, Beller A, Nguyen TT, Steinhauser G, Berek C. The long-Term survival of plasma cells. Scand J Immunol 2011; 73: 508-511
49. Manz RA, Radbruch A. Plasma cells for a lifetime? Eur J Immunol 2002; 32: 923-927
50. O'Connor BP, Cascalho M, Noelle RJ. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J Exp Med 2002; 195: 737-745
51. Belnoue E, Pihlgren M, McGaha TL, Tougne C, Rochat AF, Bossen C et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 2008; 111: 2755-2764
52. Ellyard JI, Avery DT, Mackay CR, Tangye SG. Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: Potential roles of CXCL12, IL-6 and CD54. Eur J Immunol 2005; 35: 699-708
53. Muehlinghaus G, Cigliano L, Huehn S, Peddinghaus A, Leyendeckers H, Hauser AE et al. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 2005; 105: 3965-3971
54. van der Zwan A, Rozemuller E, Tilanus M. Sequencing based typing for HLA-DPB1: Strategy for ABI equipment. IHWG Press: Seattle, WA, USA, 2006
55. Versluis LF, Rozemuller EH, Duran K, Tilanus MG. Ambiguous DPB1 allele combinations resolved by direct sequencing of selectively amplified alleles. Tissue antigens 1995; 46: 345-349.